Moreover, CTSS was identified as novel biomarkers for diseases and physiological processes, including triple-negative breast cancer, sarcoidosis, and particulate-induced lysosomal disruption in macrophages (32–34). This evidence concerns the gene CTSS and triple-negative breast carcinoma.